scholarly article | Q13442814 |
P356 | DOI | 10.3109/09553002.2016.1145360 |
P8608 | Fatcat ID | release_y726opav7ne4damdgznw7c73fu |
P932 | PMC publication ID | 5116916 |
P698 | PubMed publication ID | 26999580 |
P50 | author | Nadia Falzone | Q56986866 |
Katherine A Vallis | Q59667308 | ||
P2093 | author name string | Lei Song | |
P2860 | cites work | Efficient, pH-triggered drug delivery using a pH-responsive DNA-conjugated gold nanoparticle. | Q52842256 |
111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. | Q54059124 | ||
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres | Q57921075 | ||
Radioimmunotherapy with radioactive nanoparticles: biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area | Q84158568 | ||
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution | Q94469548 | ||
Renal clearance of quantum dots | Q24657265 | ||
Introduction to radiobiology of targeted radionuclide therapy | Q26852029 | ||
Radiotherapy enhancement with gold nanoparticles | Q28288052 | ||
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells. | Q30571353 | ||
Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer | Q33414773 | ||
EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells | Q34075391 | ||
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine | Q34419681 | ||
Improving chemoradiotherapy with nanoparticle therapeutics | Q34564219 | ||
Gold nanoparticle imaging and radiotherapy of brain tumors in mice | Q36853281 | ||
Molecular imaging and therapy of cancer with radiolabeled nanoparticles | Q37367335 | ||
Monolayer coated gold nanoparticles for delivery applications | Q37934050 | ||
Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends | Q37946340 | ||
Radiolabeled nanoparticles for multimodality tumor imaging | Q38186026 | ||
Gold nanoparticle conjugates: recent advances toward clinical applications | Q38190087 | ||
On the dose calculation at the cellular level and its implications for the RBE of (99m)Tc and ¹²³I. | Q38990087 | ||
Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells | Q39424008 | ||
The nanomedicine revolution: part 2: current and future clinical applications. | Q39527453 | ||
ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy. | Q39557701 | ||
The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles | Q39885739 | ||
Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF. | Q40053032 | ||
Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. | Q40278223 | ||
Nuclear localization of EGF receptor and its potential new role as a transcription factor | Q40782527 | ||
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. | Q42011060 | ||
Thermal stability of DNA functionalized gold nanoparticles | Q42873705 | ||
Rigid, specific, and discrete gold nanoparticle/antibody conjugates | Q43664684 | ||
Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. | Q44576368 | ||
Gold nanoparticles as carriers for efficient transmucosal insulin delivery. | Q46868738 | ||
Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery | Q47325811 | ||
Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical. | Q47972181 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P921 | main subject | nanoparticle | Q61231 |
P304 | page(s) | 716-723 | |
P577 | publication date | 2016-03-21 | |
P1433 | published in | International Journal of Radiation Biology | Q2093427 |
P1476 | title | EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer | |
P478 | volume | 92 |
Q55334502 | 111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells. |
Q89736557 | Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Coadministration of Targeting Ligand |
Q92068202 | Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles |
Q92255791 | Laser-driven radiation: Biomarkers for molecular imaging of high dose-rate effects |
Q37678134 | Radiation dose enhancement in skin therapy with nanoparticle addition: A Monte Carlo study on kilovoltage photon and megavoltage electron beams |
Q47316470 | Radiosensitization of ultrasmall GNP-PEG-cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons. |
Q41514186 | Recent progress on nanoparticle-based drug delivery systems for cancer therapy. |
Q58764832 | Subcellular Targeting of Theranostic Radionuclides |
Q90478729 | Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody |
Q90169641 | Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy |
Search more.